Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

C9orf72-mediated neurodegeneration: mechanisms and therapeutics

C9ND

An expanded GGGGCC repeat in a non-coding region of the C9orf72 gene is the most common known cause of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The repeat RNA is transcribed and accumulates in neuronal RNA aggregates, implicating RNA toxicity as a key pathogenic mechanism. However, the pathways that lead to...

Funding Programme
Start Date
End Date
Total Funding
€ 1 985 699
European Countries Involved

Calcium-Sensing Receptor (CaSR): Therapeutics for Non-Communicable Diseases

CaSR Biomedicine

The calcium sensing receptor (CaSR) is a class C Gprotein-coupled receptor that plays a pivotal role in systemic calcium metabolism by regulating parathyroid hormone secretion and urinary Ca excretion. Abnormal CaSR function is implicated in calciotropic disorders, and in non-calciotropic disorders such as Alzheimer’s disease (AD), cardiovascular...

Funding Programme
Start Date
End Date
Total Funding
€ 3 657 195

Cell type-specific molecular analysis of epigenetic changes and transposable element derepression in Alzheimer's disease progression

CTS-TEs-ADprogress

Alzheimer’s disease (AD) is a major contributor to disease burden and healthcare costs worldwide. AD is usually diagnosed once symptoms like memory impairment become evident. However, at this point typical AD pathology such as Aβ plaques and cell death is already widespread, suggesting that molecular changes have occurred decades before symptom...

Funding Programme
Start Date
End Date
Total Funding
€ 174 806
European Countries Involved

Chair of Neuroinformatics

CONI

Neuroinformatics (NI) is now an essential approach in brain research, to organise, analyse, integrate and interpret an increasing volume of diverse, multi-dimensional, fine-grain neuroscience data. University of Ljubljana's (UL's) challenges in this field are suboptimal research management & open innovation (OI), slow pace of structural changes...

Funding Programme
Start Date
End Date
Total Funding
€ 2 499 996
European Countries Involved

Characterising protein oligomers and their role in neurodegenerative disease in humans

Oligomers

Small soluble protein aggregates play a key role in the onset and spreading of Alzheimer’s and Parkinson’s diseases. However, which oligomers are present in human disease and which are toxic remains unknown because ultrasensitive methods do not exist to detect and characterise the low concentration of oligomers, which are highly heterogeneous in...

Funding Programme
Start Date
End Date
Total Funding
€ 2 499 551
European Countries Involved

Characterising protein oligomers and their role in neurodegenerative disease in humans

Oligomers

Small soluble protein aggregates play a key role in the onset and spreading of Alzheimer’s and Parkinson’s diseases. However, which oligomers are present in human disease and which are toxic remains unknown because ultrasensitive methods do not exist to detect and characterise the low concentration of oligomers, which are highly heterogeneous...

Funding Programme
Start Date
End Date
Total Funding
€ 2 499 551
European Countries Involved

CLOUD-BASED MULTIMODAL NEUROIMAGING PLATFORM

Neurocloud

One of the main socioeconomics challenges to be faced in the next decades will be the prevalence of neurodegenerative diseases (such as Alzheimer’s and Parkinson’s) due to population ageing. Today, diagnosis, treatment and monitoring of such illness is complex, a laborious process completed by a limited set of Neurologist experts who need to...

Funding Programme
Start Date
End Date
Total Funding
€ 71 429
European Countries Involved

Cognition, ageing, and bilingualism: Investigating age-related changes in bilingual language switching and use.

CAB

Older adults show difficulties with bilingual language processing and switching compared to younger adults. For example, they need more time to switch between languages and show more cross-language intrusions. Language problems have not only been found for healthy older adults, but also in patients with dementia and Parkinson’s disease. Language...

Funding Programme
Start Date
End Date
Total Funding
€ 158 122
European Countries Involved

Cognitive Aging: From Educational Opportunities to Individual Risk Profiles

CRISP

Cognitive impairment and dementia have dramatic individual and social consequences, and create high economic costs for societies. In order to delay cognitive aging of future generations as long as possible, we need evidence about which contextual factors are most supportive for individuals to reach highest cognitive levels relative to their...

Funding Programme
Start Date
End Date
Total Funding
€ 1 148 290
European Countries Involved

Cognitive Rehabilitation Gamming System (cRGS): a novel Virtual Reality-based system for the conjunctive training of stroke-derived cognitive impairments

cRGS

The cDAC ERC Advanced project develops and validates a theory of consciousness and its application to the understanding and alleviation of its deficits. cDAC proposes that consciousness is a virtualization memory system that monitors and optimizes the real-time control of perception, cognition and action realized in a multi-layered architecture...

Funding Programme
Start Date
End Date
Total Funding
€ 150 000
European Countries Involved

Common mechanisms and pathways in Stroke and Alzheimer's disease.

CoSTREAM

Common mechanisms and pathways in Stroke and Alzheimer's disease. It has long been recognized that stroke and (Alzheimer’s Disease) AD often co-occur and have an overlapping pathogenesis. As such, these two diseases are not considered fellow travelers, but rather partners in crime. This multidisciplinary consortium includes epidemiologists...

Funding Programme
Start Date
End Date
Total Funding
€ 5 100 373
European Countries Involved

Composition and dynamics of stress granules in cerebral organoid models of frontotemporal dementia

FTD-Organoids

Frontotemporal dementia (FTD) is the second most common form of dementia. A pathological hallmark is the formation of protein aggregates that consist mainly of Tau or TDP43. Patients suffer from the degeneration of the frontal and temporal lobes with no effective treatments being available. The recent advancement of 3D brain organoid cultures grown...

Funding Programme
Start Date
End Date
Total Funding
€ 174 167
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).